期刊文献+

中国非处方药目录中适宜儿童使用的化学药分析

Analysis of Chemical Drugs Suitable for Children in Chinese Over-the-counter Drugs Catalogue
原文传递
导出
摘要 目的梳理中国非处方(over-the-counter,OTC)药目录中供儿童使用的化学药,分析药品类别和说明书规范性,查找易致用药风险的关键点,并提出改进建议。方法依据国家药品监督管理局网站公布的OTC药物说明书范本、临床专家调研的结果以及文献,确定儿童化学药OTC药目录并进行分类,调查说明书规范性和一致性。结果梳理出267种儿童OTC药,涉及18类疾病,有相当比例说明书信息不完整、不规范,且呼吸系统疾病和消化系统疾病药物种类偏少。结论应规范儿童OTC药物说明书编制和宣传,加大儿童OTC药物研发力度,加强药店从业人员培训,保障儿童OTC药物的合理、安全使用。 OBJECTIVE To sort out the chemical drugs for children in China’s over-the-counter(OTC)drugs catalogue and analyze the drug categories and the specification of the instructions,so as to find out the key points that lead to the risk of drug use,and put forward suggestions for improvement.METHODS According to the sample of OTC drugs instructions published on the website of the National Medical Products Administration,as well as the results of clinical expert investigation and literature,the OTC drugs catalog of children’s chemical drugs was determined and classified,and the investigate the standardization and consistency of the instructions.RESULTS There were 267 kinds of OTC drugs for children sorted out,involving 18 kinds of diseases.A considerable proportion of the instructions were incomplete and nonstandard,and there were few kinds of drugs for respiratory and digestive diseases.CONCLUSION The preparation and publicity of children OTC drugs instructions should be standard,the research and development of children’s OTC drugs should be strengthened,the training of pharmacy employees should be strengthened,and ensure the rational and safe use of children’s OTC drugs.
作者 鲁卓林 王晓玲 王妍 李梦雪 董亚闻 李迎春 孙燕燕 LU Zhuolin;WANG Xiaoling;WANG Yan;LI Mengxue;DONG Yawen;LI Yingchun;SUN Yanyan(Department of Pharmacy,Tianjin Children’s Hospital,Tianjin 300134,China;Department of Pharmacy,Beijing Children’s Hospital,Capital Medical University,Beijing 100045,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2023年第17期2456-2461,共6页 Chinese Journal of Modern Applied Pharmacy
关键词 非处方药 儿童 目录 说明书 over-the-counter drug children catalogue instruction
  • 相关文献

参考文献17

二级参考文献154

  • 1Jiao-Sheng Zhang,Gang Liu,Wen-Shuang Zhang,Hai-Yan Shi,Gen Lu,Chang-An Zhao,Chang-Chong Li,Yan-Qi Li,Ya-Nan Shao,Dai-Yin Tian,Ming-Jie Ding,Chun-Yan Li,Li-Juan Luo,Xiao-Yan Dong,Ping Jin,Ping Wang,Chun-Mei Zhu,Chuan-Qing Wang,Yue-Jie Zheng,Ji-Kui Deng,Mike Sharland,Ying-Fen Hsia,Kun-Ling Shen,Yong-Hong Yang.Antibiotic usage in Chinese children: a point prevalence survey[J].World Journal of Pediatrics,2018,14(4):335-343. 被引量:8
  • 2何琪莹.局部药用凝胶剂的研究新进展和新应用[J].中国药物与临床,2006,6(5):384-387. 被引量:14
  • 3宋智胜.药品分类管理应根据国情循序渐进[J].中国药事,2006,20(7):399-400. 被引量:4
  • 4吴林彬,曾繁典,李佩珍,李青.我国部分省市医务人员合理用药知识调研[J].山西医科大学学报,2007,38(7):592-594. 被引量:9
  • 5詹文强,姜华.小儿解热中空栓的制备及体外溶出度研究[J].中药新药与临床药理,2007,18(4):323-325. 被引量:10
  • 6China Food and Drug Administration. u Classification ManagementMeasures for Rx and OTC drug (trial) " ( Board Order No. 10)[EB/OL], 1999-06-18 [2012-10-06]. http://www.sda.gov.cn/WS01/CL0053/24524. html.
  • 7China Food and Drug Administration. "Drug Administration Lawof the People's Republic of China" ( President Ordor No. 45)[EB/OL]. 2001-02-28 [2012-10-06]. http://www.sda.gov.cn/WS01/CL0784/23396. html.
  • 8China Food and Drug Administration. u Regulations for Implemen-tation of the Drug Administration Law" ( State Council Order No.360) [EB/OL]. 2002-08-15 [2012-10-06]. http://www. sda.gov. cn/WS01/CL0784/23395. html.
  • 9China Food and Drug Administration. "The notice on carrying outthe swit(.h evaluation work for Rx and OTC drug" [EB/OL].2004-04-07 [2012-10-06]. http ://www. sda. gov. cn/WS01/CL0844/10268. html.
  • 10China Food and Drug Administration. "The notice on carrying outthe switch evaluation work for Rx and OTC drug" [EB/OL].2010-06-30 [2012-10-06]. http://www. sda. gov. cn/WS01/(X0844/51135. html.

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部